AiCure and Defense Health Agency to Develop Targeted PTSD Treatment for Service Members and Veterans
By optimizing personalized treatment matching, the PTSD-DT Program and AiCure aim to improve service members' quality of life and maintain troop readiness, while also informing the development of future therapies.
- By optimizing personalized treatment matching, the PTSD-DT Program and AiCure aim to improve service members' quality of life and maintain troop readiness, while also informing the development of future therapies.
- Eighty percent have at least one additional comorbidity such as depression, anxiety or substance abuse disorder, complicating diagnosis and treatment further1.
- Despite the societal, financial, and emotional strain that PTSD exerts upon patients, treatment options remain scarce, with only two FDA approved therapies.
- DHA supports the National Defense Strategy and Service Military Departments by leading the Military Health System as an integrated, highly-reliable system of readiness, medical training, and health.